Any use would be based on a thorough evaluation of the patient's condition, goals, and overall treatment plan." However, the evidence supporting BPC-157 remains limited
Because rosacea is fundamentally an inflammatory condition rooted in barrier dysfunction and immune reactivity, addressing it systemically (not just topically) can make a meaningful difference
doi: 10.3389/fphar.2024.1384834 Received 10 February 2024 Accepted 04 April 2024 Published 01 May 2024 Volume 15 - 2024 Edited by Norsham Juliana, Universiti Sains Islam Malaysia, Malaysia Reviewed by Marjanu Hikmah Elias, Universiti Sains Islam Malaysia, Malaysia Khairun Nain Bin Nor Aripin, Islamic Science University of Malaysia, Malaysia Updates Copyright 2024 Hassan, Abdel-Halim, El-Shenbaby, Helmy, Hammad, Habotta, El Nashar, Alghamdi, Aldahhan, Al-Khater, Almohaywi and Farrag
BPC-157 works more locally, concentrating its signaling at the specific injury site